Learn about innovations in cytometry for
ophtamology research
We have a novel, AI-based cytometry platform that can characterize and isolate, without labels, Retinal Cells (RCs) for cell and genetic applications. The differentiation of induced pluripotent stem cells iPSCs to become difficult to obtain cell types such as Retinal Cells is an accepted approach to create material for cell therapy research and ultimately for clinical use. To obtain cells that are both pure and “untouched”, meaning that there are no labels or other artificial markers that could confound downstream uses of the cells. The need for highly pure cell stock with no labels is a key need for the field.
Stop by and we can show you the VisionSort™ Platform. Bringing together fundamental advances in optics, microfluidics, and artificial intelligence (AI), VisionSort empowers researchers to get more from their cells.
VisionSort was designed to deliver all the capabilities you have come to expect from traditional fluorescence-only cytometers and adds the strength of morphological profiling and insights of AI. Go beyond conventional cytometry add a new dimension to your cellular analysis and sorting workflows with VisionSort.
Brands: VisionSort™
ThinkCyte